Page results
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
Information about staff who work in the Macmillan Support and Information Service.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
Latest news and developments in the Macmillan Support and Information Service
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
-
This page explains what an intra-oral scanner is and what it is used for.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
Patient information on managing pain
File results
-
FOI/2024/0496 - Outpatient procedures for 2023/24
-
FOI/2024/0495 - Voice, data and network - LAN, WLAN, data centre, WAN/ internet connectivity, SIP, telephony, teams phone system, contact centre
-
FOI/2024/0492 - Maternity consultant-led births/ obstetric theatre
-
FOI/2024/0491 - Breast cancer treatment
-
FOI/2024/0490 - Continuous pre-emptive flow model for A&E patients
-
FOI/2024/0489 - Late starts for elective theatre sessions
-
FOI/2024/0488 - Emergency Preparedness, Resilience and Response Framework (EPRR) cycle of preparedness/ exercise dates
-
FOI/2024/0473 - Elective operations cancelled for non-clinical reasons 2023/24
-
FOI/2024/0479 - Applications or systems deployed on Microsoft Azure Cloud
-
FOI/2024/0478 - Elective operations cancelled for non-clinical reasons 2021/22-2023/24